• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China Regulatory Round-up for Medical Devices in November and December 2020

China Regulatory Round-up for Medical Devices in November and December 2020

Friday, 22 January 2021 / Published in Medical Device, NMPA Registration in China

China Regulatory Round-up for Medical Devices in November and December 2020

China Regulatory Guidelines Issued / Updated

1 GB (Guobiao) mandatory standard for transfusion sets will be implemented on June 1, 2022, whilst 2 GB mandatory standards for medical electrical equipment will be implemented on May 1, 2023.

The NMPA issued regulatory guidelines (including drafts) for 16 medical devices throughout November and December 2020:

  • Technical review guidelines for household in-vitro diagnostic devices
  • Technical review guidelines for specific protein immunoassay devices
  • Technical review guidelines for prolactin detection reagents
  • Technical review guidelines for total triiodothyronine detection reagents
  • Technical review guidelines for 25 hyrdroxyvitamin D detection reagents
  • Technical review guidelines for serum amyloid A detection reagents
  • Technical review guidelines for rheumatoid factor detection reagents
  • Technical review guidelines for nomenclature of orthopaedic surgical instruments
  • Technical review guidelines for nomenclature of blood transfusion, dialysis and cardiopulmonary bypass devices
  • Technical review guidelines for nomenclature of passive surgical instruments
  • Technical review guidelines for nomenclature of passive implantable devices
  • Technical review guidelines for nomenclature of disinfection and sterilization devices
  • Technical review guidelines for electronic upper gastrointestinal endoscope
  • Technical review guidelines for fundus camera
  • Technical review guidelines (draft) for biodegradable magnesium orthopaedic implants
  • Technical review guidelines (draft) for the use of in-vitro diagnostic reagents overseas clinical trial data

China Fast-Track Approval Updates

Amongst the applicants of the 5 medical devices pending for registration approval via the Special Review Procedure for Innovative Medical Devices, the application of the intraocular lens was submitted by Alcon Laboratories, Incorporated, an American-Swiss medical company specializing in eye care products.

The Hepatitis B virus PCR fluorescence quantitative detection kit is pending for registration approval via the Procedure for Prioritized Review, and considered as a major project in China’s national science and technology field. The applicant is a local manufacturer in Suzhou, China.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: fast-track approval, Guobiao, Prioritized Review, Special Review Procedure, Technical Review Guidelines

What you can read next

Advertisement of Life Science Products
China IVD Reagent Registration and Review Guidelines
China IVD Reagent Registration and Review Guidelines Updates have been issued
New Clinical Trial Exemption Lists for Medical Devices and IVDs

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.